Repurposing CRISPR/Cas13 systems for therapeutic mRNA trans-splicing in cardiac and musculoskeletal disorders
Publication
, Conference
Fiflis, DN; Lavanya, HV; Sewell, B; Benkert, AR; Asokan, A
Published in: HUMAN GENE THERAPY
2025
Duke Scholars
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
2025
Volume
36
Issue
3-4
Start / End Page
E259 / E259
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
Citation
APA
Chicago
ICMJE
MLA
NLM
Fiflis, D. N., Lavanya, H. V., Sewell, B., Benkert, A. R., & Asokan, A. (2025). Repurposing CRISPR/Cas13 systems for therapeutic mRNA trans-splicing in cardiac and musculoskeletal disorders. In HUMAN GENE THERAPY (Vol. 36, pp. E259–E259).
Fiflis, D. N., H. V. Lavanya, B. Sewell, A. R. Benkert, and A. Asokan. “Repurposing CRISPR/Cas13 systems for therapeutic mRNA trans-splicing in cardiac and musculoskeletal disorders.” In HUMAN GENE THERAPY, 36:E259–E259, 2025.
Fiflis DN, Lavanya HV, Sewell B, Benkert AR, Asokan A. Repurposing CRISPR/Cas13 systems for therapeutic mRNA trans-splicing in cardiac and musculoskeletal disorders. In: HUMAN GENE THERAPY. 2025. p. E259–E259.
Fiflis, D. N., et al. “Repurposing CRISPR/Cas13 systems for therapeutic mRNA trans-splicing in cardiac and musculoskeletal disorders.” HUMAN GENE THERAPY, vol. 36, no. 3–4, 2025, pp. E259–E259.
Fiflis DN, Lavanya HV, Sewell B, Benkert AR, Asokan A. Repurposing CRISPR/Cas13 systems for therapeutic mRNA trans-splicing in cardiac and musculoskeletal disorders. HUMAN GENE THERAPY. 2025. p. E259–E259.
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
2025
Volume
36
Issue
3-4
Start / End Page
E259 / E259
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology